Rocket One Inc. Convertible Notes Payable
Rocket One Inc. (RKTO) had Convertible Notes Payable of $50.00 thousand as of 2022-09-10, per its 10-Q filed 2022-11-10.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified › Notes Payable
us-gaap:ConvertibleNotesPayable · last filed 2024-03-28
- 2022-09-10: Convertible Notes Payable $50.00K.
- 2020-09-30: Convertible Notes Payable $50.00K.
- 2020-09-10: Convertible Notes Payable $50.00K.
| Period end | Convertible Notes Payable |
|---|---|
| 2022-09-10 | $50.00K 10-Q · filed 2022-11-10 |
| 2020-09-30 | $50.00K 10-Q · filed 2020-11-10 |
| 2020-09-10 | $50.00K 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |